Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years’ experience ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-01

AUTHORS

Sinziana Radesi-Sarghi, Flavie Arbion, Caroline Dartigeas, Martine Delain, Lotfi Benboubker, Olivier Hérault, Philippe Colombat, Emmanuel Gyan

ABSTRACT

Maintenance interferon alpha (IFN-α) immunotherapy after induction chemotherapy prolongs progression-free survival (PFS) in untreated follicular lymphoma (FL). Little information is available about IFN-α use in relapsed FL. This study aims to evaluate the benefit of IFN-α as a treatment of low-burden FL relapse. This single-centre retrospective study identified 20 patients treated in 27 cases with IFN-α. We analysed all cases of IFN-α treatment in patients with low-burden FL in clinical relapse (11), partial response (5) or only with molecular minimal residual disease (MRD; 5). The treatment schedule was 3MIU IFN-α three times a week alone (16) or combined with four weekly rituximab (R; 11), according to the institution's policy. Except for the molecular relapses, responses were evaluated according to the IWG 1999 criteria. MRD was defined as a repeatedly detectable BCL2-IgH rearrangement in peripheral blood or bone marrow. In 22 cases of clinical relapses or partial responders, overall response rate was 68 %, with 55 % complete responses. Median PFS was 20.9 months (95 % confidence interval (95 % CI), 0-64.9) with 20.9 and 48.7 months in the IFN and R-IFN groups, respectively (p = 0.4). The median PFS of the five MRD cases was 133 months (95 % CI, 103-165). The Follicular Lymphoma International Prognostic Index score calculated at initiation of IFN-α treatment was predictive of time to relapse (p = 0.036). These results compare favourably with previous reports of the efficacy of R alone, and of R with IFN-α in relapse. Further research is required to explore the role of IFN-α in the management of FL. More... »

PAGES

147-156

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-013-1934-7

DOI

http://dx.doi.org/10.1007/s00277-013-1934-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020569702

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24232218


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fran\u00e7ois Rabelais University", 
          "id": "https://www.grid.ac/institutes/grid.12366.30", 
          "name": [
            "Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnell\u00e9, 37044, Tours Cedex 9, France", 
            "Facult\u00e9 de M\u00e9decine, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Radesi-Sarghi", 
        "givenName": "Sinziana", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Service d\u2019Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arbion", 
        "givenName": "Flavie", 
        "id": "sg:person.01245723467.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245723467.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnell\u00e9, 37044, Tours Cedex 9, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dartigeas", 
        "givenName": "Caroline", 
        "id": "sg:person.01123634737.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123634737.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnell\u00e9, 37044, Tours Cedex 9, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Delain", 
        "givenName": "Martine", 
        "id": "sg:person.0774655407.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774655407.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnell\u00e9, 37044, Tours Cedex 9, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benboubker", 
        "givenName": "Lotfi", 
        "id": "sg:person.01003012622.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003012622.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Facult\u00e9 de M\u00e9decine, Tours, France", 
            "Service d\u2019H\u00e9matologie Biologique, Centre Hospitalier Universitaire, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00e9rault", 
        "givenName": "Olivier", 
        "id": "sg:person.01150633106.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150633106.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fran\u00e7ois Rabelais University", 
          "id": "https://www.grid.ac/institutes/grid.12366.30", 
          "name": [
            "Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnell\u00e9, 37044, Tours Cedex 9, France", 
            "Facult\u00e9 de M\u00e9decine, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Colombat", 
        "givenName": "Philippe", 
        "id": "sg:person.0640025523.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640025523.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Tours", 
          "id": "https://www.grid.ac/institutes/grid.411167.4", 
          "name": [
            "Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnell\u00e9, 37044, Tours Cedex 9, France", 
            "Facult\u00e9 de M\u00e9decine, Tours, France", 
            "Centre d\u2019Investigation Clinique, INSERM U202, Centre Hospitalier Universitaire, Tours, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gyan", 
        "givenName": "Emmanuel", 
        "id": "sg:person.01007177364.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007177364.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00002371-200101000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009231519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200101000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009231519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1023668705040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013396541", 
          "https://doi.org/10.1023/a:1023668705040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2010.030320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015910712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-04-1323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019072310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mds177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019214656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-12-4434", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027887474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-10-250555", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028285144"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-04-153189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029707044"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.5827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032157696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428199609052435", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033268735"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.06.146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034555212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd004629.pub2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034652268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.reprotox.2011.11.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034833206"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-03-143537", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037648451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.12.191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039034126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v97.1.101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041990794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)62175-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042074696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2008.07565.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042886061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-03-1110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042923821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10428190701704647", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047190799"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-06-228890", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048843679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdf146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052226211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1992.tb08202.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052743435"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199311253292203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052783860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0959-8049(95)00374-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053077757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/714052707", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058426460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/107999000750053799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059206805"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.4.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.6.1851", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074674917", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.17.3135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074691573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074873217", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082390841", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.3.1110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083057227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083095803", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083238839", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.8.2825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083306005"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-01", 
    "datePublishedReg": "2014-01-01", 
    "description": "Maintenance interferon alpha (IFN-\u03b1) immunotherapy after induction chemotherapy prolongs progression-free survival (PFS) in untreated follicular lymphoma (FL). Little information is available about IFN-\u03b1 use in relapsed FL. This study aims to evaluate the benefit of IFN-\u03b1 as a treatment of low-burden FL relapse. This single-centre retrospective study identified 20 patients treated in 27 cases with IFN-\u03b1. We analysed all cases of IFN-\u03b1 treatment in patients with low-burden FL in clinical relapse (11), partial response (5) or only with molecular minimal residual disease (MRD; 5). The treatment schedule was 3MIU IFN-\u03b1 three times a week alone (16) or combined with four weekly rituximab (R; 11), according to the institution's policy. Except for the molecular relapses, responses were evaluated according to the IWG 1999 criteria. MRD was defined as a repeatedly detectable BCL2-IgH rearrangement in peripheral blood or bone marrow. In 22 cases of clinical relapses or partial responders, overall response rate was 68\u00a0%, with 55\u00a0% complete responses. Median PFS was 20.9\u00a0months (95\u00a0% confidence interval (95\u00a0% CI), 0-64.9) with 20.9 and 48.7\u00a0months in the IFN and R-IFN groups, respectively (p\u2009=\u20090.4). The median PFS of the five MRD cases was 133\u00a0months (95\u00a0% CI, 103-165). The Follicular Lymphoma International Prognostic Index score calculated at initiation of IFN-\u03b1 treatment was predictive of time to relapse (p\u2009=\u20090.036). These results compare favourably with previous reports of the efficacy of R alone, and of R with IFN-\u03b1 in relapse. Further research is required to explore the role of IFN-\u03b1 in the management of FL.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00277-013-1934-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "93"
      }
    ], 
    "name": "Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years\u2019 experience in a single centre", 
    "pagination": "147-156", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "62030c2524cb5fd9fa743beebd29a0bfc20ce73454e859e30fb10d098fc27524"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24232218"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-013-1934-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020569702"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-013-1934-7", 
      "https://app.dimensions.ai/details/publication/pub.1020569702"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000487.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00277-013-1934-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1934-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1934-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1934-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1934-7'


 

This table displays all metadata directly associated to this object as RDF triples.

238 TRIPLES      21 PREDICATES      66 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-013-1934-7 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Naa72833ad66044578ce1a7c6b047ed98
4 schema:citation sg:pub.10.1023/a:1023668705040
5 https://app.dimensions.ai/details/publication/pub.1074674917
6 https://app.dimensions.ai/details/publication/pub.1074873217
7 https://app.dimensions.ai/details/publication/pub.1082390841
8 https://app.dimensions.ai/details/publication/pub.1083095803
9 https://app.dimensions.ai/details/publication/pub.1083238839
10 https://doi.org/10.1002/14651858.cd004629.pub2
11 https://doi.org/10.1016/0959-8049(95)00374-6
12 https://doi.org/10.1016/j.reprotox.2011.11.003
13 https://doi.org/10.1016/s0140-6736(10)62175-7
14 https://doi.org/10.1056/nejm199311253292203
15 https://doi.org/10.1080/10428190701704647
16 https://doi.org/10.1080/714052707
17 https://doi.org/10.1089/107999000750053799
18 https://doi.org/10.1093/annonc/mdf146
19 https://doi.org/10.1093/annonc/mds177
20 https://doi.org/10.1097/00002371-200101000-00007
21 https://doi.org/10.1111/j.1365-2141.1992.tb08202.x
22 https://doi.org/10.1111/j.1365-2141.2008.07565.x
23 https://doi.org/10.1182/blood-2003-12-4434
24 https://doi.org/10.1182/blood-2004-03-1110
25 https://doi.org/10.1182/blood-2004-04-1323
26 https://doi.org/10.1182/blood-2008-03-143537
27 https://doi.org/10.1182/blood-2008-04-153189
28 https://doi.org/10.1182/blood-2009-06-228890
29 https://doi.org/10.1182/blood-2009-10-250555
30 https://doi.org/10.1182/blood.v97.1.101
31 https://doi.org/10.1200/jco.1997.15.3.1110
32 https://doi.org/10.1200/jco.1998.16.8.2825
33 https://doi.org/10.1200/jco.1999.17.4.1244
34 https://doi.org/10.1200/jco.1999.17.6.1851
35 https://doi.org/10.1200/jco.2000.18.17.3135
36 https://doi.org/10.1200/jco.2005.06.146
37 https://doi.org/10.1200/jco.2005.12.191
38 https://doi.org/10.1200/jco.2009.26.5827
39 https://doi.org/10.3109/10428199609052435
40 https://doi.org/10.3324/haematol.2010.030320
41 schema:datePublished 2014-01
42 schema:datePublishedReg 2014-01-01
43 schema:description Maintenance interferon alpha (IFN-α) immunotherapy after induction chemotherapy prolongs progression-free survival (PFS) in untreated follicular lymphoma (FL). Little information is available about IFN-α use in relapsed FL. This study aims to evaluate the benefit of IFN-α as a treatment of low-burden FL relapse. This single-centre retrospective study identified 20 patients treated in 27 cases with IFN-α. We analysed all cases of IFN-α treatment in patients with low-burden FL in clinical relapse (11), partial response (5) or only with molecular minimal residual disease (MRD; 5). The treatment schedule was 3MIU IFN-α three times a week alone (16) or combined with four weekly rituximab (R; 11), according to the institution's policy. Except for the molecular relapses, responses were evaluated according to the IWG 1999 criteria. MRD was defined as a repeatedly detectable BCL2-IgH rearrangement in peripheral blood or bone marrow. In 22 cases of clinical relapses or partial responders, overall response rate was 68 %, with 55 % complete responses. Median PFS was 20.9 months (95 % confidence interval (95 % CI), 0-64.9) with 20.9 and 48.7 months in the IFN and R-IFN groups, respectively (p = 0.4). The median PFS of the five MRD cases was 133 months (95 % CI, 103-165). The Follicular Lymphoma International Prognostic Index score calculated at initiation of IFN-α treatment was predictive of time to relapse (p = 0.036). These results compare favourably with previous reports of the efficacy of R alone, and of R with IFN-α in relapse. Further research is required to explore the role of IFN-α in the management of FL.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree false
47 schema:isPartOf N4c77db79b9d740a7941f4fc729577607
48 N9487b828e01e4a41ad17804891b53ad1
49 sg:journal.1018247
50 schema:name Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years’ experience in a single centre
51 schema:pagination 147-156
52 schema:productId N42da938e341448ada216836691e940d3
53 N470351050e6d4cc391bbb213cabe9ab1
54 N91b1983ff0994380b1b25742d6220d49
55 Nb06e11c744e34dd98aea48553efb9f0d
56 Ned06987cef8440878f23998dd73ee46b
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020569702
58 https://doi.org/10.1007/s00277-013-1934-7
59 schema:sdDatePublished 2019-04-11T00:10
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N125b5712d3324a0986b6d6c0fa71f973
62 schema:url http://link.springer.com/10.1007/s00277-013-1934-7
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N125b5712d3324a0986b6d6c0fa71f973 schema:name Springer Nature - SN SciGraph project
67 rdf:type schema:Organization
68 N1ee0c25532e64b6b9018558630adb875 rdf:first sg:person.01150633106.14
69 rdf:rest N582742170be84535aa8a9a8c6efc47f9
70 N2019259a68634eaab0dbd71f31a28919 schema:name Service d’Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnellé, 37044, Tours Cedex 9, France
71 rdf:type schema:Organization
72 N42da938e341448ada216836691e940d3 schema:name pubmed_id
73 schema:value 24232218
74 rdf:type schema:PropertyValue
75 N470351050e6d4cc391bbb213cabe9ab1 schema:name nlm_unique_id
76 schema:value 9107334
77 rdf:type schema:PropertyValue
78 N4c77db79b9d740a7941f4fc729577607 schema:volumeNumber 93
79 rdf:type schema:PublicationVolume
80 N582742170be84535aa8a9a8c6efc47f9 rdf:first sg:person.0640025523.43
81 rdf:rest Nb3aca47f5b5b4271837ba445f2c735fa
82 N666792d688d245fda0d7540fba337b65 rdf:first sg:person.0774655407.97
83 rdf:rest N876edf2ca26b45fbb7dc85250fca1bb3
84 N6e44982776a947788973fa9ccc87ff11 rdf:first sg:person.01123634737.32
85 rdf:rest N666792d688d245fda0d7540fba337b65
86 N876edf2ca26b45fbb7dc85250fca1bb3 rdf:first sg:person.01003012622.32
87 rdf:rest N1ee0c25532e64b6b9018558630adb875
88 N91b1983ff0994380b1b25742d6220d49 schema:name dimensions_id
89 schema:value pub.1020569702
90 rdf:type schema:PropertyValue
91 N9487b828e01e4a41ad17804891b53ad1 schema:issueNumber 1
92 rdf:type schema:PublicationIssue
93 N99ace5273e3a46069f400523adbdcf41 schema:name Service d’Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnellé, 37044, Tours Cedex 9, France
94 rdf:type schema:Organization
95 N9cc7c7cef49a42a28a3e81674e9bd72e rdf:first sg:person.01245723467.90
96 rdf:rest N6e44982776a947788973fa9ccc87ff11
97 Naa72833ad66044578ce1a7c6b047ed98 rdf:first Nccba675248b34648bf82f25136684b76
98 rdf:rest N9cc7c7cef49a42a28a3e81674e9bd72e
99 Nb06e11c744e34dd98aea48553efb9f0d schema:name doi
100 schema:value 10.1007/s00277-013-1934-7
101 rdf:type schema:PropertyValue
102 Nb3aca47f5b5b4271837ba445f2c735fa rdf:first sg:person.01007177364.11
103 rdf:rest rdf:nil
104 Ncc1253f0878740a6ba39d2c8bd10006e schema:name Service d’Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnellé, 37044, Tours Cedex 9, France
105 rdf:type schema:Organization
106 Nccba675248b34648bf82f25136684b76 schema:affiliation https://www.grid.ac/institutes/grid.12366.30
107 schema:familyName Radesi-Sarghi
108 schema:givenName Sinziana
109 rdf:type schema:Person
110 Ned06987cef8440878f23998dd73ee46b schema:name readcube_id
111 schema:value 62030c2524cb5fd9fa743beebd29a0bfc20ce73454e859e30fb10d098fc27524
112 rdf:type schema:PropertyValue
113 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
114 schema:name Medical and Health Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
117 schema:name Oncology and Carcinogenesis
118 rdf:type schema:DefinedTerm
119 sg:journal.1018247 schema:issn 1269-3286
120 1279-8509
121 schema:name Annals of Hematology
122 rdf:type schema:Periodical
123 sg:person.01003012622.32 schema:affiliation Ncc1253f0878740a6ba39d2c8bd10006e
124 schema:familyName Benboubker
125 schema:givenName Lotfi
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003012622.32
127 rdf:type schema:Person
128 sg:person.01007177364.11 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
129 schema:familyName Gyan
130 schema:givenName Emmanuel
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007177364.11
132 rdf:type schema:Person
133 sg:person.01123634737.32 schema:affiliation N99ace5273e3a46069f400523adbdcf41
134 schema:familyName Dartigeas
135 schema:givenName Caroline
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123634737.32
137 rdf:type schema:Person
138 sg:person.01150633106.14 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
139 schema:familyName Hérault
140 schema:givenName Olivier
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150633106.14
142 rdf:type schema:Person
143 sg:person.01245723467.90 schema:affiliation https://www.grid.ac/institutes/grid.411167.4
144 schema:familyName Arbion
145 schema:givenName Flavie
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245723467.90
147 rdf:type schema:Person
148 sg:person.0640025523.43 schema:affiliation https://www.grid.ac/institutes/grid.12366.30
149 schema:familyName Colombat
150 schema:givenName Philippe
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640025523.43
152 rdf:type schema:Person
153 sg:person.0774655407.97 schema:affiliation N2019259a68634eaab0dbd71f31a28919
154 schema:familyName Delain
155 schema:givenName Martine
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774655407.97
157 rdf:type schema:Person
158 sg:pub.10.1023/a:1023668705040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013396541
159 https://doi.org/10.1023/a:1023668705040
160 rdf:type schema:CreativeWork
161 https://app.dimensions.ai/details/publication/pub.1074674917 schema:CreativeWork
162 https://app.dimensions.ai/details/publication/pub.1074873217 schema:CreativeWork
163 https://app.dimensions.ai/details/publication/pub.1082390841 schema:CreativeWork
164 https://app.dimensions.ai/details/publication/pub.1083095803 schema:CreativeWork
165 https://app.dimensions.ai/details/publication/pub.1083238839 schema:CreativeWork
166 https://doi.org/10.1002/14651858.cd004629.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034652268
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/0959-8049(95)00374-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053077757
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/j.reprotox.2011.11.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034833206
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s0140-6736(10)62175-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042074696
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1056/nejm199311253292203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052783860
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1080/10428190701704647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047190799
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1080/714052707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058426460
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1089/107999000750053799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059206805
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1093/annonc/mdf146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052226211
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1093/annonc/mds177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019214656
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1097/00002371-200101000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009231519
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1111/j.1365-2141.1992.tb08202.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052743435
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1111/j.1365-2141.2008.07565.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042886061
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1182/blood-2003-12-4434 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027887474
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1182/blood-2004-03-1110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042923821
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1182/blood-2004-04-1323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019072310
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1182/blood-2008-03-143537 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037648451
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1182/blood-2008-04-153189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029707044
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1182/blood-2009-06-228890 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048843679
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1182/blood-2009-10-250555 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028285144
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1182/blood.v97.1.101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041990794
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1200/jco.1997.15.3.1110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083057227
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1200/jco.1998.16.8.2825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083306005
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1200/jco.1999.17.4.1244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549729
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1200/jco.1999.17.6.1851 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549773
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1200/jco.2000.18.17.3135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074691573
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1200/jco.2005.06.146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034555212
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1200/jco.2005.12.191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039034126
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1200/jco.2009.26.5827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032157696
223 rdf:type schema:CreativeWork
224 https://doi.org/10.3109/10428199609052435 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033268735
225 rdf:type schema:CreativeWork
226 https://doi.org/10.3324/haematol.2010.030320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015910712
227 rdf:type schema:CreativeWork
228 https://www.grid.ac/institutes/grid.12366.30 schema:alternateName François Rabelais University
229 schema:name Faculté de Médecine, Tours, France
230 Service d’Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnellé, 37044, Tours Cedex 9, France
231 rdf:type schema:Organization
232 https://www.grid.ac/institutes/grid.411167.4 schema:alternateName Centre Hospitalier Universitaire de Tours
233 schema:name Centre d’Investigation Clinique, INSERM U202, Centre Hospitalier Universitaire, Tours, France
234 Faculté de Médecine, Tours, France
235 Service d’Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire, Tours, France
236 Service d’Hématologie Biologique, Centre Hospitalier Universitaire, Tours, France
237 Service d’Hématologie et Thérapie Cellulaire, Centre Hospitalier Universitaire, 2 boulevard Tonnellé, 37044, Tours Cedex 9, France
238 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...